Erythrocytes and thrombo-erythrocytes as target specific abents

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 5/08 (2006.01) A61K 9/50 (2006.01) A61K 35/18 (2006.01) A61K 47/48 (2006.01) A61K 49/00 (2006.01) C07K 7/06 (2006.01) C07K 14/75 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2095925

2095925 9208804 PCTABS00013 The present invention provides new compounds and methods for promoting platelet aggregation, and controlling bleeding. The present invention is based on the surprising discovery that erythrocytes conjugated to certain peptides and polypeptides containing an R-G-D (Arg-Gly-Asp) sequence (collectively termed herein "RGD peptides") according to the invention, selectively bind to activated platelets but not to unactivated platelets. In recognition of the dual nature of the derivatized erythrocytes, they are termed herein "thrombo-erythrocytes". The thrombo-erythrocytes have no significant change in their rheological properties. In a preferred aspect, the thrombo-erythrocytes have the majority of RGD peptide cross-linked specifically to glycophorin A and glycophorin B on the surface of the erythrocyte. In the thrombo-erythrocytes of the invention, preferably, the N-terminal Arg of the R-G-D sequence should be spaced within 9-50 Angstroms, more preferably 10-40 Angstroms, and most preferably 11-25 Angstroms, from the erythrocyte protein to which the RGD peptide is conjugated. The invention is further directed to erythrocytes modified by replacement of their intracellular contents with a composition comprising a label or agent. Such modified erythrocytes are termed herein "carrier erythrocytes". The carrier erythrocytes have use in delivery of such labels or biologically active agents to specific tissues by conjugation to a targeting agent.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Erythrocytes and thrombo-erythrocytes as target specific abents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythrocytes and thrombo-erythrocytes as target specific abents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythrocytes and thrombo-erythrocytes as target specific abents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1488368

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.